Velardi Enrico, Tsai Jennifer J, Holland Amanda M, Wertheimer Tobias, Yu Vionnie W C, Zakrzewski Johannes L, Tuckett Andrea Z, Singer Natalie V, West Mallory L, Smith Odette M, Young Lauren F, Kreines Fabiana M, Levy Emily R, Boyd Richard L, Scadden David T, Dudakov Jarrod A, van den Brink Marcel R M
Immunology Program, Department of Medicine, and Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065 Department of Clinical and Experimental Medicine, University of Perugia, 06122 Perugia, Italy
Immunology Program, Department of Medicine, and Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065 Department of Immunology and Microbial Pathogenesis, Weill Cornell Medical College, New York, NY 10021.
J Exp Med. 2014 Nov 17;211(12):2341-9. doi: 10.1084/jem.20131289. Epub 2014 Oct 20.
Paradoxical to its importance for generating a diverse T cell repertoire, thymic function progressively declines throughout life. This process has been at least partially attributed to the effects of sex steroids, and their removal promotes enhanced thymopoiesis and recovery from immune injury. We show that one mechanism by which sex steroids influence thymopoiesis is through direct inhibition in cortical thymic epithelial cells (cTECs) of Delta-like 4 (Dll4), a Notch ligand crucial for the commitment and differentiation of T cell progenitors in a dose-dependent manner. Consistent with this, sex steroid ablation (SSA) led to increased expression of Dll4 and its downstream targets. Importantly, SSA induced by luteinizing hormone-releasing hormone (LHRH) receptor antagonism bypassed the surge in sex steroids caused by LHRH agonists, the gold standard for clinical ablation of sex steroids, thereby facilitating increased Dll4 expression and more rapid promotion of thymopoiesis. Collectively, these findings not only reveal a novel mechanism underlying improved thymic regeneration upon SSA but also offer an improved clinical strategy for successfully boosting immune function.
尽管胸腺对于产生多样化的T细胞库至关重要,但其功能在整个生命过程中却逐渐衰退。这一过程至少部分归因于性类固醇的作用,去除性类固醇可促进胸腺生成增强以及从免疫损伤中恢复。我们发现,性类固醇影响胸腺生成的一种机制是通过直接抑制皮质胸腺上皮细胞(cTECs)中的Delta样4(Dll4),Dll4是一种Notch配体,对T细胞祖细胞的定向和分化至关重要,且呈剂量依赖性。与此一致的是,性类固醇消融(SSA)导致Dll4及其下游靶点的表达增加。重要的是,由促黄体生成素释放激素(LHRH)受体拮抗作用诱导的SSA绕过了LHRH激动剂引起的性类固醇激增,LHRH激动剂是临床上性类固醇消融的金标准,从而促进了Dll4表达的增加以及胸腺生成的更快促进。总体而言,这些发现不仅揭示了SSA后胸腺再生改善的新机制,还提供了一种成功增强免疫功能的改进临床策略。